ESR1 and breast carcinoma: Orai3 has been reported to be highly expressed in the estrogen receptor-positive (ER+) breast cancer cell lines MCF7, ZR751, T47D, and HCC1500 [31] as well as in luminal breast cancer tissues as compared to non-tumoral breast epithelial cells and adjacent non-cancerous tissues [32,33].